Atlas Trials

Atezolizumab + Pertuzumab + Trastuzumab In CNS Mets In BC

Clinical trial NCT03417544 · COMPLETED

Trial details

NCT number
NCT03417544
Sponsor
Nancy Lin, MD
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
HER2-positive Metastatic Breast CancerCentral Nervous System Metastases
Start date
2018-05-21
Primary completion
2020-05-20
Enrollment
19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.